The influence of benzquinamide, oxypertine and prenylamine on monoamine levels and on monoamine effects in the spinal cord.
D000577:Amides / Q000494:pharmacology*; D000818:Animals; D004298:Dopamine / Q000378:metabolism; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010649:Phenylalanine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology*; D011807:Quinolizines / Q000494:pharmacology*; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013116:Spinal Cord / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000577:Amides; D007211:Indoles; D011807:Quinolizines; D014149:Tranquilizing Agents; D012701:Serotonin; D010649:Phenylalanine; D012110:Reserpine; D011299:Prenylamine; D009526:Nialamide; D004298:Dopamine; D009638:Norepinephrine